Anti-Insulin + Proinsulin antibody [D6C4]
4
(6 리뷰들)
|
(41 제품이 사용된 논문 )
- Over 30 publications
- Trusted since 2002
Reactivity 정보
제품 세부 정보
Anti-Insulin + Proinsulin antibody [D6C4] (ab8304) is a mouse monoclonal antibody and is validated for use in ELISA in Cow, Human, Mouse, Pig, Rat samples.
Trusted by the scientific community
Anti-Insulin + Proinsulin [D6C4] (ab8304) was first used in a scientific publication in 2002 and has been cited over 30 times in peer-reviewed journals.
Reviewed by scientists
Anti-Insulin + Proinsulin [D6C4] (ab8304) has over 5 independent reviews from customers.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Insulin and proinsulin are indispensable for maintaining glucose homeostasis in the body. Insulin binds to its receptor a receptor tyrosine kinase on target cells like muscle and adipose tissue to facilitate glucose uptake. Proinsulin also has a lesser-known role in insulin regulation and folding. It mostly exists independently rather than being part of a complex with insulin but precursor and mature insulin forms can transiently appear together during synthesis and secretion.
Pathways
Insulin function fits significantly into the signaling pathways such as the insulin signaling pathway and the PI3K/AKT pathway. These pathways importantly involve glucose transporters like GLUT4 and proteins such as IRS-1 that mediate insulin's effects on glucose and lipid metabolism. Insulin signals lead to the translocation of GLUT4 to the plasma membrane enhancing glucose uptake. Therefore insulin is closely related to these critical metabolic pathways.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (41)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Anais da Academia Brasileira de Ciencias 97:e20240807 PubMed40136201
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:8812 PubMed40087321
2025
Applications
Unspecified application
Species
Unspecified reactive species
Endocrinology 166: PubMed39844660
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 300:107425 PubMed38823639
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e31049 PubMed38803977
2024
Applications
Unspecified application
Species
Unspecified reactive species
ACS pharmacology & translational science 7:1650-1663 PubMed38751616
2024
Applications
Unspecified application
Species
Unspecified reactive species
Drug delivery and translational research 13:1699-1715 PubMed36587110
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of physiology 600:1611-1630 PubMed35128667
2022
Applications
Unspecified application
Species
Unspecified reactive species
Atherosclerosis 326:47-55 PubMed33933263
2021
Applications
Unspecified application
Species
Unspecified reactive species
mAbs 13:1864084 PubMed33382949
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com